Smoking cessation pharmacotherapy based on genetically-informed biomarkers: what is the evidence?
<p><strong>Introduction:</strong> Pharmacogenomic studies have used genetic variants to identify smokers likely to respond to pharmacological treatments for smoking cessation. Methods:We performed a systematic review and meta-analysis of primary and secondary analyses of trials of...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2019
|